adenosine amine congener has been researched along with 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine in 2 studies
| Studies (adenosine amine congener) | Trials (adenosine amine congener) | Recent Studies (post-2010) (adenosine amine congener) | Studies (8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine) | Trials (8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine) | Recent Studies (post-2010) (8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine) |
|---|---|---|---|---|---|
| 29 | 0 | 5 | 108 | 0 | 14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Barone, S; Jacobson, KA; Kammula, U; Stiles, GL | 1 |
1 review(s) available for adenosine amine congener and 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
1 other study(ies) available for adenosine amine congener and 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine
| Article | Year |
|---|---|
Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors.
Topics: Adenosine; Animals; In Vitro Techniques; Purines; Rats; Receptors, Purinergic; Structure-Activity Relationship; Xanthine; Xanthines | 1989 |